| 000 | 01490 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516204720.0 | ||
| 264 | 0 | _c20141201 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1520-5711 | ||
| 024 | 7 |
_a10.1080/10543406.2014.888570 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHabteab Ghebretinsae, Aklilu | |
| 245 | 0 | 0 |
_aAssessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial. _h[electronic resource] |
| 260 |
_bJournal of biopharmaceutical statistics _c2014 |
||
| 300 |
_a660-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 |
_aClinical Trials, Phase III as Topic _xmethods |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndpoint Determination _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLikelihood Functions |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aPatient Dropouts _xstatistics & numerical data |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 700 | 1 | _aMolenberghs, Geert | |
| 700 | 1 | _aDmitrienko, Alex | |
| 700 | 1 | _aOffen, Walt | |
| 700 | 1 | _aSethuraman, Gopalan | |
| 773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 24 _gno. 3 _gp. 660-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543406.2014.888570 _zAvailable from publisher's website |
| 999 |
_c23704184 _d23704184 |
||